G01N 33/5073
Stem cells
Official title: {Stem cells}
G01N33/5073 (Stem cells) appears on 467 US grants and 1,027 published applications in this corpus.
Search patents in G01N- Granted patents
- 467
- Published applications
- 1,027
- Assignees
- 516
- Inventors
- 1,946
- Latest grant
- 16 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1998 | 5 | 0 |
| 1999 | 6 | 0 |
| 2000 | 4 | 0 |
| 2001 | 8 | 3 |
| 2002 | 5 | 10 |
| 2003 | 4 | 20 |
| 2004 | 4 | 22 |
| 2005 | 3 | 32 |
| 2006 | 10 | 32 |
| 2007 | 5 | 35 |
| 2008 | 8 | 51 |
| 2009 | 10 | 40 |
| 2010 | 21 | 41 |
| 2011 | 16 | 43 |
| 2012 | 29 | 51 |
| 2013 | 16 | 45 |
| 2014 | 29 | 57 |
| 2015 | 21 | 53 |
| 2016 | 36 | 65 |
| 2017 | 26 | 68 |
| 2018 | 30 | 56 |
| 2019 | 35 | 32 |
| 2020 | 33 | 54 |
| 2021 | 26 | 62 |
| 2022 | 11 | 39 |
| 2023 | 18 | 30 |
| 2024 | 21 | 39 |
| 2025 | 22 | 23 |
| 2026 | 5 | 24 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Composition for inhibiting growth of cancer stem cells16 Jun 2026US 12,653,816 B2Industry-Academic Cooperation Foundation, Yonsei University
- Stem cell-derived Schwann cells19 May 2026US 12,630,801 B2Memorial Sloan Kettering Cancer Center
- Methods for evaluating cardiac safety of drug using cardiomyocytes derived from human stem cells10 Mar 2026US 12,571,791 B2Nexel Co., Ltd.
- Application of TGF-B inhibitor in inducing neural stem cells and organoid formation10 Feb 2026US 12,545,892 B2Iregene Therapeutics Ltd
- Human in vitro cardiotoxicity model20 Jan 2026US 12,529,694 B2Brown University
- System and method for capillary blood stem cell reprogramming using upper-arm blood collection devices for patient-specific disease modeling10 Sep 2026US 2026/0265698 A1TimepointDx
- Tissue engineered tube using stem cell, and method for producing same20 Aug 2026US 2026/0242745 A1Tohoku University
- Cgmp compliant differentiation of ipscs to iecs23 Jul 2026US 2026/0209715 A1Cedars-Sinai Medical Center
- Itih5 for use in the treatment of obesity16 Jul 2026US 2026/0199430 A1
- Cytokine storm suppressor, method for using cytokine storm suppressor and screening method9 Jul 2026US 2026/0191910 A1Dexon Pharmaceuticals Inc.
Most cited
By later US patents
- Vascularized perfused microtissue/micro-organ arrays324US 6,197,575 B1Massachusetts Institute of Technology · 2001
- In vitro growth and proliferation of genetically modified multipotent neural stem cells and their progeny316US 5,750,376 ANeurospheres Holdings Ltd. · 1998
- In vitro growth and proliferation of multipotent neural stem cells and their progeny265US 5,851,832 ANeurospheres, Ltd. · 1998
- Isolation propagation and directed differentiation of stem cells from embryonic and adult central nervous system of mammals223US 5,753,506 ACNS Stem Cell Technology, Inc. · 1998
- Miniaturized cell array methods and apparatus for cell-based screening177US 6,548,263 B1Cellomics, Inc. · 2003